(129 days)
Not Found
No
The summary describes a standard dental implant system and does not mention any software, algorithms, or capabilities that would suggest the use of AI or ML. The performance studies focus on mechanical testing, not algorithmic performance.
Yes
The device, a dental implant system, directly replaces missing teeth to support restorations, which is a therapeutic intervention.
No
Explanation: The device is described as a dental implant system used for replacing missing teeth, which is a therapeutic rather than a diagnostic function. There is no mention of it being used to identify or analyze a condition.
No
The device description explicitly lists physical components such as dental implants, abutments, screws, and surgical instruments made of Titanium alloy. This indicates a hardware-based medical device, not a software-only one.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices intended to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Description and Intended Use: The provided text clearly describes a dental implant system used to replace missing teeth. It is surgically implanted into the bone and supports dental restorations. This is a device used in vivo (within the body), not in vitro (in a test tube or lab setting).
- Lack of Diagnostic Function: The device's purpose is structural and restorative, not to diagnose a condition or provide information about a patient's health through testing of samples.
Therefore, based on the provided information, the Hahn Implants are not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Hahn Implants are indicated for use in maxillary and mandibular partially or fully edentulous cases, to support single, multiple-unit, and overdenture restorations. The implants are to be used for immediate loading only in the presence of primary stability and appropriate occlusal loading.
Product codes (comma separated list FDA assigned to the subject device)
DZE
Device Description
The Hahn Tapered Implant System consists of dental implants, abutments, screws, and surgical instruments. They are manufactured from Titanium alloy, grade 23. The implant is designed with an internal hex connection and a tapered body to replace one or more missing teeth. The surface is blasted with Hydroxyl Apatite and acid etched to facilitate osseointegration. The Implants are design with two (2) platform connection geometries; they are available in the following diameters: 3.0mm, 3.5mm, 4. 3mm, 5.0mm, and 7. 0mm diameter is available in the following lengths: 8mm, 10mm, 11.5mm, 13mm, and 16mm. The dental implants are provided sterile (gamma radiation).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Oral Cavity
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical test data was used to evaluate the device's performance, and determine substantial equivalence with predicate devices.
Non-clinical testing was performed in accordance with FDA Guidance "Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments" and it consisted of Reliability Calculation, Fatigue Testing and Static Load Failure Testing of finished assembled implant/abutment systems.
The testing performed established that the predicate device is as safe, as effective, and performs as well as the predicate device(s).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol representing the human form, composed of three abstract figures facing to the right.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 2, 2015
Prismatik Dentalcraft, Inc. Mr. Brandon Shepard Regulatory Affairs & Quality Assurance Specialist 2212 Dupont Drive, Suite P Irvine, California 92612
Re: K143353 Trade/Device Name: Hahn Tapered Implant System
Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE Dated: March 2, 2015 Received: March 3, 2015
Dear Mr. Shepard:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply
1
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tina
Kiang -S
for Erin I. Keith, M.S. Division Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Image /page/2/Picture/0 description: The image contains the logo for Prismatik Dentalcraft, Inc. On the left side of the logo is a triangle with different colors. The text "PRISMATIK DENTALCRAFT, INC." is on the right side of the triangle.
S | A F |
---|---|
--- | ----- |
Indications for Use Statement
DEPARTMENT OF HEALTH AND HUMAN SERVICES | |
---|---|
Food and Drug Administration | |
Indications for Use | |
510(k) Number (if known) | K143353 |
Device Name | Hahn Tapered Implant System |
Indications for Use (Describe) | Hahn Implants are indicated for use in maxillary and mandibular partially or fully edentulous cases, to support single, multiple-unit, and overdenture restorations. The implants are to be used for immediate loading only in the presence of primary stability and appropriate occlusal loading. |
Type of Use (Select one or both, as applicable) | |
Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) |
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120
Expiration Date: January 31, 2017
See PRA Statement below.
FORM FDA 3881 (1/14)
Page 1 of 1
PSC Publishing Services (301) 443-6740 EF
3
Image /page/3/Picture/0 description: The image shows the logo for PRISMATIK DENTALCRAFT, INC. The logo consists of a colorful triangle on the left and the company name on the right. The triangle is divided into several sections, each with a different color. The company name is written in blue, with "PRISMATIK" on the top line and "DENTALCRAFT, INC." on the bottom line.
005 510(k) Summary
[As Required by 21 CFR 807.92]
This 510(k) summary of substantial equivalence information is being submitted in accordance with the requirements 21 CFR 807.92.
SUBMITTER INFORMATION A.
B.
Company Name: | PRISMATIK DENTALCRAFT, INC | |
---|---|---|
Company Address: | 2212 Dupont Dr., Suite P | |
Irvine, CA 92612 | ||
Company Phone / Fax: | (949) 225-1269 / (978) 313-0850 | |
Contact Person: | Primary Contact: | |
Brandon Shepard, (949) 225-1243 | ||
Secondary Contact: | ||
Marilyn Pourazar, (949) 225-1269 | ||
Date Summary Prepared: | March 2, 2015 | |
DEVICE IDENTIFICATION | ||
Trade/Proprietary Name: | Hahn Tapered Implant System. | |
Common Name: | Endosseous Dental Implant System | |
Regulation Number: | 872.3640 | |
Product Code: | DZE | |
Device Class: | 2 | |
Review Panel: | Dental |
4
Image /page/4/Picture/0 description: The image shows the logo for Prismatik Dentalcraft, Inc. On the left is a triangle with a gradient of colors, including pink, blue, yellow, and green. To the right of the triangle is the text "PRISMATIK DENTALCRAFT, INC." The text is in a sans-serif font and is blue.
IDENTIFICATION OF PREDICATE DEVICE C.
Trade/Proprietary Name: Inclusive Tapered Implant System (K121406)
DEVICE DESCRIPTION D.
The Hahn Tapered Implant System consists of dental implants, abutments, screws, and surgical instruments. They are manufactured from Titanium alloy, grade 23. The implant is designed with an internal hex connection and a tapered body to replace one or more missing teeth. The surface is blasted with Hydroxyl Apatite and acid etched to facilitate osseointegration. The Implants are design with two (2) platform connection geometries; they are available in the following diameters: 3.0mm, 3.5mm, 4. 3mm, 5.0mm, and 7. 0mm diameter is available in the following lengths: 8mm, 10mm, 11.5mm, 13mm, and 16mm. The dental implants are provided sterile (gamma radiation).
E. INDICATIONS FOR USE
Hahn Implants are indicated for use in maxillary and mandibular partially or fully edentulous cases, to support single, multiple-unit, and overdenture restorations. The implants are to be used for immediate loading only in the presence of primary stability and appropriate occlusal loading.
F. NON-CLINICAL TESTING
Non-clinical test data was used to evaluate the device's performance, and determine substantial equivalence with predicate devices.
Non-clinical testing was performed in accordance with FDA Guidance "Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Implant Abutments" and it consisted of Reliability Calculation, Fatigue Testing and Static Load Failure Testing of finished assembled implant/abutment systems.
The testing performed established that the predicate device is as safe, as effective, and performs as well as the predicate device(s).
SUBSTANTIAL EQUIVALENCE STATEMENT G.
The proposed device is substantially equivalent with the predicate (K121406) in regards to intended use, materials, design, and performance. In conclusion, the testing and evaluations conducted demonstrate that Hahn Tapered Implant System performs as well as the predicate device.
(See Comparison Tables below).
5
Image /page/5/Picture/0 description: The image shows the logo for Prismatik Dentalcraft, Inc. On the left is a triangle with a prism-like design, featuring a spectrum of colors. To the right of the triangle are the words "PRISMATIK" and "DENTALCRAFT, INC." stacked on top of each other. The text is in a blue sans-serif font.
Comparison of Predicate and Proposed Devices
Attributes | Predicate Device | Proposed Device | Similarities / Differences | |
---|---|---|---|---|
Device Name | Inclusive Tapered Implant | |||
System (K121406) | Hahn Tapered Implant | |||
System | ||||
Indications for Use | Inclusive Tapered Implants | |||
are indicated for use in | ||||
maxillary and mandibular | ||||
partially or fully edentulous | ||||
cases, to support single, | ||||
multiple-unit, and | ||||
overdenture restorations. | ||||
The implants are to be used | ||||
for immediate loading only | ||||
in the presence of primary | ||||
stability and appropriate | ||||
occlusal loading. | Hahn Implants are indicated | |||
for use in maxillary and | ||||
mandibular partially or fully | ||||
edentulous cases, to support | ||||
single, multiple-unit, and | ||||
overdenture restorations. The | ||||
implants are to be used for | ||||
immediate loading only in the | ||||
presence of primary stability | ||||
and appropriate occlusal | ||||
loading. | Same | |||
Surface | Blasted with Hydroxyl | |||
Apatite | Blasted with Hydroxyl | |||
Apatite | Same | |||
Connection | Internal Hex | Internal Hex | Same | |
Design | Threaded root-form implant | Threaded root-form implant | Same | |
Implant Body | ||||
Geometry | Screw Type | Screw Type | Same | |
Diameters (mm) | 3.7, 4.7, 5.2 | 3.0, 3.5, 4.3, 5.0, and 7.0 | Additional | |
Sizes | ||||
Lengths (mm) | 8, 10, 11.5, 13, and 16 | 8, 10, 11.5, 13, and 16 | Same | |
Sterility | Packaged Sterile | Packaged Sterile | Same | |
Material | Titanium Alloy, Grade 23 | Titanium Alloy, Grade 23 | Same | |
Abutment Angle | 0°-20° | 0°-30° | Increased | |
Angulation | ||||
Range | ||||
Abutment Seat | Sits on a taper | Sits on a taper | Same | |
Screw Seat | Sits on a flat | Sits on a taper | Tapered vs. | |
Flat | ||||
Anatomical Site | Oral Cavity | Oral Cavity | Same | |
Construction | Machined | Machined | Same | |
Conclusion | All differences between the predicate and proposed devices have been evaluated | |||
per the testing described in section F (non-clinical testing) and the proposed | ||||
device has performed as well as the predicate; the devices are substantially | ||||
equivalent. |